CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 4 Open-market sale Chief R&D Officer sold 21,673 shares at $3.95 ($85,608)
- 4 Open-market sale SVP & General Counsel sold 3,136 shares at $3.95 ($12,387)
- 4 Open-market sale SVP & Chief Accounting Officer sold 5,841 shares at $3.95 ($23,072)
- 4 Open-market sale President & CEO sold 36,529 shares at $3.95 ($144,290)
- 4 Open-market sale SVP & Chief Commercial Officer sold 4,592 shares at $3.95 ($18,138)
- 4 Open-market sale SVP, COO & CFO sold 17,448 shares at $3.95 ($68,920)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Exit or restructuring costs · Impairment
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Chief R&D Officer sold 10,912 shares at $10.95 ($119,486)
- 4 Open-market sale SVP & General Counsel sold 3,661 shares at $10.95 ($40,088)
Page 18 of 100 · 1,982 filings